Old weapon, new target: Dasatinib against angioimmunoblastic T-cell lymphoma
Researchers from the University of Tsukuba, Japan, show that angioimmunoblastic T-cell lymphoma (AITL) is dependent…
Browsing: Lymphoma
DNA topological problems may cause lymphoma
Researchers from the Spanish National Cancer Research Centre (CNIO), Madrid, and the Andalusian Molecular Biology…
New front opened in fight against common cancer driver
Walter and Eliza Hall Institute researchers have revealed a new vulnerability in lymphomas that are…
New study finds cellular immunotherapy treatment associated with improved quality of life
Adult lymphoma patients whose disease was effectively treated with chimeric antigen receptor T-cell (CAR-T) therapy…
CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukaemia and lymphoma
According to results from a Phase I/IIa trial at The University of Texas MD Anderson…
Drug profiling and gene scissors open new avenues in immunotherapy
Researchers have discovered ways to boost CAR T-cell therapy. According to a study published in…
Cancer treatment: study finds targeting nearby ‘normal’ cells could improve survival rates
Ingo Ringshausen, University of Cambridge Cancer of the immune system, lymphoma or leukaemia, generally affects…
Protein inhibitor shown as potential treatment approach for common mutations found in non-Hodgkin lymphomas
Findings may create immunotherapy options for lymphomas caused by CREBBP mutations A study at The…
New treatment options for aggressive lymphomas
Combining a new anti-cancer drug targeting Mcl-1 with current cancer therapies could be an effective…
Lymphoma patients may have new path to remission, even when CAR T therapy fails
A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant…